Differences in etiology and treatment in Scandinavian countries

Abstract

We here review the studies of IgA nephropathy (IgAN) performed in the Scandinavian countries Denmark, Finland, Iceland, Norway, and Sweden, with emphasis on the etiologic and prognostic factors as well as the treatment of IgAN. During the last decades, most of the published studies about IgAN have come from Sweden and Finland, whereas there are only few reports from the other Scandinavian countries thus far.